1. Home
  2. ADAG vs HSPO Comparison

ADAG vs HSPO Comparison

Compare ADAG & HSPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • HSPO
  • Stock Information
  • Founded
  • ADAG 2011
  • HSPO 2014
  • Country
  • ADAG China
  • HSPO United States
  • Employees
  • ADAG N/A
  • HSPO N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • HSPO Blank Checks
  • Sector
  • ADAG Health Care
  • HSPO Finance
  • Exchange
  • ADAG Nasdaq
  • HSPO Nasdaq
  • Market Cap
  • ADAG 81.9M
  • HSPO 92.0M
  • IPO Year
  • ADAG 2021
  • HSPO 2022
  • Fundamental
  • Price
  • ADAG $2.06
  • HSPO $11.65
  • Analyst Decision
  • ADAG Strong Buy
  • HSPO
  • Analyst Count
  • ADAG 1
  • HSPO 0
  • Target Price
  • ADAG $8.00
  • HSPO N/A
  • AVG Volume (30 Days)
  • ADAG 31.8K
  • HSPO 3.5K
  • Earning Date
  • ADAG 03-09-2025
  • HSPO 01-01-0001
  • Dividend Yield
  • ADAG N/A
  • HSPO N/A
  • EPS Growth
  • ADAG N/A
  • HSPO 2.63
  • EPS
  • ADAG N/A
  • HSPO 0.28
  • Revenue
  • ADAG $815,746.00
  • HSPO N/A
  • Revenue This Year
  • ADAG N/A
  • HSPO N/A
  • Revenue Next Year
  • ADAG $2.70
  • HSPO N/A
  • P/E Ratio
  • ADAG N/A
  • HSPO $41.35
  • Revenue Growth
  • ADAG N/A
  • HSPO N/A
  • 52 Week Low
  • ADAG $1.64
  • HSPO $10.80
  • 52 Week High
  • ADAG $3.65
  • HSPO $12.41
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 62.66
  • HSPO 48.83
  • Support Level
  • ADAG $1.64
  • HSPO $11.70
  • Resistance Level
  • ADAG $1.95
  • HSPO $11.78
  • Average True Range (ATR)
  • ADAG 0.10
  • HSPO 0.07
  • MACD
  • ADAG 0.04
  • HSPO -0.02
  • Stochastic Oscillator
  • ADAG 91.30
  • HSPO 0.00

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About HSPO Horizon Space Acquisition I Corp.

Horizon Space Acquisition I Corp is a blank check company.

Share on Social Networks: